SIREN : 318684107
SAS JARMAT is a French company founded 46 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in REVENTIN-VAUGRIS (38121), this company of category PME shows in 2024 a revenue of 7.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | 7 814 409 € | 7 866 950 € | N/C | N/C | N/C | 5 781 899 € | 5 793 137 € | 5 943 387 € | 6 303 721 € |
| Net income | 562 430 € | 419 512 € | 407 346 € | 578 215 € | 569 497 € | 354 120 € | 234 870 € | 400 908 € | 435 717 € | 411 893 € |
| EBITDA | N/C | 627 899 € | 826 499 € | N/C | N/C | N/C | 372 916 € | 280 394 € | 747 295 € | 696 307 € |
| Net margin | N/C | 5.4% | 5.2% | N/C | N/C | N/C | 4.1% | 6.9% | 7.3% | 6.5% |
In 2025, SAS JARMAT generates positive net income of 562 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 412 k€ -> 562 k€.
562 430 €
The debt ratio (= Financial debt / Equity x 100) stands at 7%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 81%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
7.199%
81.43%
18.9%
In 2025, the debt ratio of SAS JARMAT (7.20) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2025, the financial autonomy of SAS JARMAT (81.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of SAS JARMAT (0.89) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 714.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
714.297
In 2025, the liquidity ratio of SAS JARMAT (714.30) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of SAS JARMAT (3.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Indicative estimate only : the number of comparable transactions in this sector is limited (27 transactions). This range of 112 215€ to 344 906€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 27 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SAS JARMAT with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques
The revenue of SAS JARMAT in 2024 is 7.8 M€.
Yes, SAS JARMAT generated a net profit of 562 k€ in 2025.
The headquarters of SAS JARMAT is located in REVENTIN-VAUGRIS (38121), in the department Isere.
The tax return of SAS JARMAT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SAS JARMAT operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.